1-10 of 10
toxicity tests
Close
Sort by
Journal Articles

Development of Novel Highly Specific FLT3 Targeted Inhibitors for Combination or Sequential Therapy of Acute Myeloid Leukemia

Misbah Sabir, MSc, Monica Hellesoy, PhD, Jarno Kivioja, MSc, Caroline Engen, MD, Claire Amiable, Mihaela Popa, Remi Guillon, Øystein Bruserud, MD PhD, Caroline A Heckman, PhD, Emmet McCormack, BSc, PhD, Dominique Surleraux, Bjørn Tore Gjertsen
Journal: Blood
Blood (2017) 130 (Supplement 1): 3349.
https://doi.org/10.1182/blood.V130.Suppl_1.3349.3349
Published: 2017
Journal Articles

Design, Optimization, and Pre-Clinical Evaluation of Direct, Mechanism-Based STAT3 Inhibitors for Treating Myeloid Disorders

William L. Heaton, M.S., Anna M. Eiring, PhD, Nadeem A. Vellore, PhD, Diana Resetca, B.S., Sina Haftchenary, PhD, David Rosa, PhD, Ahmed M. Ali, Anna V. Senina, M.S., Anthony D. Pomicter, M.S., Brent D.G. Page, PhD, Ira L. Kraft, B.S., Kimberly R. Reynolds, M.S., Derek J. Wilson, PhD, Riccardo Baron, PhD, Thomas O'Hare, PhD, Patrick T. Gunning, PhD, Michael W. Deininger
Journal: Blood
Blood (2014) 124 (21): 4816.
https://doi.org/10.1182/blood.V124.21.4816.4816
Published: 2014
Journal Articles

New Xenograft Method For Studying Leukemia and Drug Response In Turkey Embryos

Varda R Deutsch, PhD, Sigi Kay, PhD, Yona Farnoushi, MSc, Erez Matalon, MSc, Tal Ohayon, MSc, Shoshana Baron, Hila Jan, MSc, Elizabeth Naparstek, MD, Michal Cipok, PhD
Journal: Blood
Blood (2013) 122 (21): 3973.
https://doi.org/10.1182/blood.V122.21.3973.3973
Published: 2013
Journal Articles

Efficacy Trial In An Acute Liver Trauma Animal Model Of Novel Infusible Hemostatic Product: Red Blood Cell-Derived Microparticles (RMP)

Wenche Jy, PhD, Max E Johansen, BS, Carlos Bidot, Jr., BS, Rifat Pamukcu, MD, Orlando Gomez-Marin, PhD, Eugene Ahn, MD, Lawrence L Horstman, BS, Yeon S Ahn, MD
Journal: Blood
Blood (2013) 122 (21): 2342.
https://doi.org/10.1182/blood.V122.21.2342.2342
Published: 2013
Journal Articles

A Recombinant Antibody to EphA3 for the Treatment of Hematologic Malignancies: Research Update and Interim Phase 1 Study Results

Anne Hagey, M.D., Jeffrey E. Lancet, MD, Varghese Palath, PhD, Andrew H Wei, MBBS, PhD, Martin Lackmann, PhD, Jorge E. Cortes, Andrew Boyd, MD, PhD, Dan Shochat, PhD, Geoffrey Yarranton, PhD, Christopher Bebbington, DPhil., Jonathan A. Leff, MD
Journal: Blood
Blood (2011) 118 (21): 4893.
https://doi.org/10.1182/blood.V118.21.4893.4893
Published: 2011
Journal Articles

The Biocompatibility and Security of Magnetic Nanoparticles Fe 3 O 4 -DNR Used In Hematologic Malignancies Therapy

Bao-An Chen, MD, PhD, Wei-wei Wu, Jian Cheng, Jun Wang, Feng Gao, Wen-lin Xu, Chong Gao, Jia-hua Ding, Yun-yu Sun, Hui-hui Song, Wen Bao, Li-jie Liu, Guo-hua Xia, Xue-mei Wang
Journal: Blood
Blood (2010) 116 (21): 3970.
https://doi.org/10.1182/blood.V116.21.3970.3970
Published: 2010
Journal Articles

The Anti-Malarial Mefloquine Demonstrates Preclinical Activity In Leukemia and Myeloma, and Is Dependent Upon Toll-Like Receptor Signaling for Its Cytotoxicity

Mahadeo A. Sukhai, PhD, Xiaoming Li, PhD, Rose Hurren, Xiaoming Wang, Skrtic Marko, B.Sc., Hong Sun, Marcela Gronda, Ayesh Seneviratne, Dilan Dissanayake, Sue Chow, Rod Bremner, PhD, David Hedley, MD, Mark D. Minden, MD, PhD, Ohashi Pamela, PhD, FRSC, Aaron Schimmer, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 290.
https://doi.org/10.1182/blood.V116.21.290.290
Published: 2010
Journal Articles

The Antihelmintic Flubendazole Inhibits Microtubules through a Mechanism Distinct From Vinca Alkaloids and Displays Preclinical Activity in Leukemia and Myeloma.

Paul A. Spagnuolo, PhD, Jiayi Hu, Rose Hurren, Ashley Di Meo, Jonathan Boss, Iman Ashali, Marcela Gronda, Xiaoming Wang, Reza Behesti Zavareh, Sumaiya Sharmeen, Noah Fine, Craig D Simpson, Robert Rottapel, MD, Aaron D. Schimmer, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1017.
https://doi.org/10.1182/blood.V114.22.1017.1017
Published: 2009
Journal Articles

Methyl Dehydro-Jasmonate Has Anti-Inflammatory Effect Cells and Its Molecular Targets Mir-155 and NF-Kb Pathway against LPS Stimulation On RAW264.7.

Hye-Ja Lee, Hung-The Dang, Gyeoung-Jin Kang, Jee H Jung, PhD, Hee-Kyoung Kang, Hyejin Shin, MS, Josef T. Prchal, MD, Eun-Sook Yoo, PhD, Donghoon Yoon, PhD
Journal: Blood
Blood (2009) 114 (22): 1357.
https://doi.org/10.1182/blood.V114.22.1357.1357
Published: 2009
Journal Articles

Organic Arsenic Lipid Derivatives Are More Potent and Less Toxic Than Inorganic Arsenic Trioxide in Preclinical Testing.

Xiaodong Cheng, M.D., Mirna Golemovic, M.S., Francis Giles, M.D., Ralph Zingaro, Ph.D., Ming-Zhang Gao, Ph.D., Emil J. Freireich, M.D., Michael Andreeff, M.D., Ph.D., Hagop M. Kantarjian, M.D., Srdan Verstovsek, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1803.
https://doi.org/10.1182/blood.V104.11.1803.1803
Published: 2004